ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

DALIRESP
Asthma/COPD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

DALIRESP Rx

Generic Name and Formulations:
Roflumilast 250mcg, 500mcg; tabs.

Company:
AstraZeneca Pharmaceuticals

Therapeutic Use:

Indications for DALIRESP:

To reduce risk of COPD exacerbations in severe COPD patients with chronic bronchitis and a history of exacerbations.

Limitations Of use:

Not for the relief of acute bronchospasm. Daliresp 250mcg is a starting dose only and is not the effective dose.

Adult:

Maintenance: 500mcg once daily. Initiating 250mcg once daily for 4 weeks, then increasing to 500mcg once daily thereafter may reduce the rate of discontinuation in some patients.

Children:

Not established.

Contraindications:

Moderate-to-severe liver impairment (Child-Pugh B or C).

Warnings/Precautions:

History of depression. Suicidal ideation. Monitor for new or worsening insomnia, anxiety, depression, suicidal thoughts, other mood changes; reevaluate if occur. Mild liver impairment (Child-Pugh A). Monitor weight regularly; consider discontinuing if unexplained or significant weight loss occurs. Pregnancy. Labor & delivery, nursing mothers: not recommended.

Pharmacological Class:

Selective phosphodiesterase 4 (PDE4) inhibitor.

Interactions:

Concomitant strong CYP450 inducers (eg, rifampicin, phenobarbital, carbamazepine, phenytoin): not recommended. Potentiated by CYP3A4 and CYP1A2 inhibitors (eg, erythromycin, ketoconazole, fluvoxamine, enoxacin, cimetidine), and by oral contraceptives containing gestodene + ethinyl estradiol (possible increased adverse effects).

Adverse Reactions:

Diarrhea, weight loss, nausea, headache, back pain, influenza, dizziness, decreased appetite; psychiatric effects (eg, insomnia, anxiety, depression).

How Supplied:

Tabs 250mcg—28; 500mcg—30, 90

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs